Pembrolizumab (Anti-PD-1) and AMG386 (Angiopoietin-2 (Ang-2) in Patients With Advanced Solid Tumor
Dana-Farber Cancer Institute
Dana-Farber Cancer Institute
Tizona Therapeutics, Inc
Essen Biotech
Takeda
Novartis
University of Pittsburgh
Coherus Oncology, Inc.
DEKA Biosciences
Inhibrx Biosciences, Inc
Celldex Therapeutics
Corvus Pharmaceuticals, Inc.
Kineta Inc.
Syndax Pharmaceuticals